“morningside-ventures” Archives

in
Entry Author Date Location
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections 08/12/20 Europe
Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery 07/22/20 Boston
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s 07/01/20 Boston
Pinteon Gets $17M to Tackle Tau in Alzheimer’s, Other Brain Diseases 10/31/19 Boston
Meissa Scores $30M to Test Vaccine for Dangerous Respiratory Virus 09/26/19 San Francisco
InCarda Breathes In $42M for Clinical Tests of Inhalable Heart Drug 11/08/18 San Francisco
Boston Tech Watch: Nuance, Relayr, Markforged, Grapevine & More 09/07/18 Boston
First Clinical Trial Done, Elysium Lands $20M for Health Supplements 12/06/16 New York
Austin Biotech Mirna Therapeutics Nabs Nearly $42M in Series D Funding 04/30/15 Texas
Texas Roundup: DNAtrix, Nanolinea, Wireless Seismic, Illumitex, TMCx 10/20/14 Texas
West Coast Biotech Roundup: Illumina, Atara, Invitae, Canaan & More 10/17/14 San Francisco
Indel Grabs $1.4M for Antibiotics 04/28/11 Seattle
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News 01/05/11 Boston
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business 01/03/11 Boston
Alnylam’s Spinoff Strategy, Genzyme’s Gaucher-Business Future, Adimab’s Antibody Ambitions, & More Boston-Area Life Sciences News 02/25/09 Boston
Vertex’s $320M SPO, Verenium and BP’s Joint Venture, Genocea’s $23M Series A, & More Boston-Area Deals News 02/20/09 Boston
Genocea Biosciences Closes $23M Series A, Adds New CEO Bakali 02/19/09 Boston
Page 1 of 1